Viseon Inc. Completes New Investment Round To Expand Market Opportunities for Its Technologies

IRVINE, Calif.--(BUSINESS WIRE)--Viseon Inc. announces the completion of an insider financing round. The financing will enable further 4K-ADV™ product development and market expansion focusing on several exciting fronts where digitization of open and minimally invasive surgery can facilitate clinical and economic benefits. Deployment and adoption of Viseon technology continues expansion in the spine market with 2024 Year to Date growth up more than 22% compared to the same period in 2023.

Pete Davis, Viseon’s President and Chief Operating Officer, stated, “We are pleased to have the ongoing support and conviction of our investors. The additional funding will allow Viseon to focus on corporate value drivers in the development of new technology, generating a positive response from the investment community and supported by our clinicians and distributor network. Additionally, we continue to serve our Spine market customers, resulting in repeatable quarter over quarter growth, expanding distribution and building corporate relationships.

“We continue to hear that better visualization with our MaxView^® 4K technology equates to increased safety, better training, better ergonomics and improved workflow, improving overall OR efficiency. We continue refining resource management to streamline our investment priorities and broadening the applications for our newer technologies.”

About Viseon Inc.: Viseon Inc. is privately owned with a founding goal to advance open and minimally invasive surgery with innovative technology that enhances intraoperative visualization, provides novel therapeutic instruments that improve patient care in an otherwise compromised setting. In doing so the Company is disrupting antiquated modalities for visualization, enabling the digital future, and accelerating adoption of advanced surgical techniques while improving the surgeon experience, patient outcomes and safety, and introducing economic benefits to the hospital and surgery center.